Uncategorized
Opinion: The life sciences executive search crisis: When “cutting to the bone” backfires
The 2022 search approach is no longer working. Companies need to think critically about how they are acquiring top regulatory, clinical and commercial executives or risk their programs in this new regulatory and market reality.